Citations

Clear

3 citation(s) found for "Steiger, Hans-Jakob".

Surgical treatment of brainstem cavernous malformations: an international Delphi consensus
Dammann, Philipp , Abla, Adib A. , Salman, Rustam Al‐Shahi , Cenzato, Marco , Connolly, E. Sander , Cornelius, Jan F. , Hauck, Erik F. , Hernesniemi, Juha , Kivelev, Juri , MacDonald, Ryan , Ogilvy, Christopher S. , Steiger, Hans‐Jakob , Steinberg, Gary K. , Rauschenbach, Laurèl , Schmidt, Börge , Spetzler, Robert F., Schaller, Karl , Lawton, Michael T. , Abla, Adib , Ogilvy, Christopher S , Al-Shahi Salman, Rustam , Steinberg, Gary K , Rauschenbach, Laurèl , Andrade-Barazarte, Hugo , Beneš, Vladimír , Couldwell, William T. , Sola, Rafael García de , Gomez‐Paz, Santiago , Lanzino, Giuseppe , Macdonald, R. Loch, Morcos, Jacques J. , Santos, Alejandro N. , Oppong, Marvin Darkwah , Sure, Ulrich

Mayo Clinic

Journal of Neurosurgery | October 1, 2021 | Volume: 136 | Issue: 5 | Pages: 1220-1230

10.3171/2021.3.jns2156 | PMID 34598135 Get It

OBJECTIVE Indication for surgery in brainstem cavernous malformations (BSCMs) is based on many case series, few comparative studies, and no randomized controlled trials. The objective of this study was to seek consensus about surgical management aspects of BSCM. METHODS A total of 29 experts were invited to participate in a multistep Delphi consensus process on the surgical treatment of BSCM. RESULTS Twenty-two (76%) of 29 experts participated in the consensus. Qualitative analysis (content analysis) of an initial open-ended question survey resulted in 99 statements regarding surgical treatment of BSCM. By using a multistep survey with 100% participation in each round, consensus was reached on 52 (53%) of 99 statements. These were grouped into 4 categories: 1) definitions and reporting standards (7/14, 50%); 2) general and patient-related aspects (11/16, 69%); 3) anatomical-, timing of surgery–, and BSCM-related aspects (22/37, 59%); and 4) clinical situation–based decision-making (12/32, 38%). Among other things, a consensus was reached for surgical timing, handling of associated developmental venous anomalies, handling of postoperative BSCM remnants, assessment of specific anatomical BSCM localizations, and treatment decisions in typical clinical BSCM scenarios. CONCLUSIONS A summary of typical clinical scenarios and a catalog of various BSCM- and patient-related aspects that influence the surgical treatment decision have been defined, rated, and interpreted.
Age of Collagen in Intracranial Saccular Aneurysms
Etminan, Nima , Dreier, Rita , Buchholz, Bruce A. , Beseoglu, Kerim , Brückner, Peter , Matzenauer, Christian, Torner, James C., Brown, Robert D., Steiger, Hans-Jakob, Hänggi, Daniel , Macdonald, R. Loch , Torner, James C.

Mayo Clinic

Stroke | April 30, 2014 | Volume: 45 | Issue: 6 | Pages: 1757-1763

10.1161/strokeaha.114.005461 | PMID 24781080 Get It

Background and Purpose— The chronological development and natural history of cerebral aneurysms (CAs) remain incompletely understood. We used 14 C birth dating of a main constituent of CAs, that is, collagen type I, as an indicator for biosynthesis and turnover of collagen in CAs in relation to human cerebral arteries to investigate this further. Methods— Forty-six ruptured and unruptured CA samples from 43 patients and 10 cadaveric human cerebral arteries were obtained. The age of collagen, extracted and purified from excised CAs, was estimated using 14 C birth dating and correlated with CA and patient characteristics, including the history of risk factors associated with atherosclerosis and potentially aneurysm growth and rupture. Results— Nearly all CA samples contained collagen type I, which was <5 years old, irrespective of patient age, aneurysm size, morphology, or rupture status. However, CAs from patients with a history of risk factors (smoking or hypertension) contained significantly younger collagen than CAs from patients with no risk factors (mean, 1.6±1.2 versus 3.9±3.3 years, respectively; P =0.012). CAs and cerebral arteries did not share a dominant structural protein, such as collagen type I, which would allow comparison of their collagen turnover. Conclusions— The abundant amount of relatively young collagen type I in CAs suggests that there is an ongoing collagen remodeling in aneurysms, which is significantly more rapid in patients with risk factors. These findings challenge the concept that CAs are present for decades and that they undergo only sporadic episodes of structural change.
Multidisciplinary Consensus on Assessment of Unruptured Intracranial Aneurysms
Etminan, Nima , Beseoglu, Kerim , Barrow, Daniel L. , Bederson, Joshua B. , Brown, Robert D., Connolly, E. Sander , Derdeyn, Colin P. , Hänggi, Daniel , Hasan, David , Juvela, Seppo , Kasuya, Hidetoshi , Kirkpatrick, Peter J., Knuckey, Neville W., Koivisto, Timo , Lawton, Michael T. , LeRoux, Peter D. , McDougall, Cameron G. , Mee, Edward , Molyneux, Andrew , Morgan, Michael K. , Mori, Kentaro , Morita, Akio , Nagahiro, Shinji, Pasqualin, A., Raabe, Andreas , Raymond, Jean , Rüfenacht, Daniel A. , Seifert, Volker , Spears, Julian , Steiger, Hans-Jakob, Steinmetz, Helmuth , Torner, James C., Vajkoczy, Peter , Wanke, Isabel , Wong, George Kwok Chu , Wong, John H. , Macdonald, R. Loch, Torner, James C. , Lanzino, Giuseppe , Mocco, J , Murayama, Yuichi , Rinkel, Gabriël J.E. , Morita, Akio , Barrow, Daniel L , Derdeyn, Colin P

Mayo Clinic

Stroke | March 25, 2014 | Volume: 45 | Issue: 5 | Pages: 1523-1530

10.1161/strokeaha.114.004519 | PMID 24668202 Get It

Background and Purpose— To address the increasing need to counsel patients about treatment indications for unruptured intracranial aneurysms (UIA), we endeavored to develop a consensus on assessment of UIAs among a group of specialists from diverse fields involved in research and treatment of UIAs. Methods— After composition of the research group, a Delphi consensus was initiated to identify and rate all features, which may be relevant to assess UIAs and their treatment by using ranking scales and analysis of inter-rater agreement (IRA) for each factor. IRA was categorized as very high, high, moderate, or low. Results— Ultimately, 39 specialists from 4 specialties agreed (high or very high IRAs) on the following key factors for or against UIA treatment decisions: (1) patient age, life expectancy, and comorbid diseases; (2) previous subarachnoid hemorrhage from a different aneurysm, family history for UIA or subarachnoid hemorrhage, nicotine use; (3) UIA size, location, and lobulation; (4) UIA growth or de novo formation on serial imaging; (5) clinical symptoms (cranial nerve deficit, mass effect, and thromboembolic events from UIAs); and (6) risk factors for UIA treatment (patient age and life expectancy, UIA size, and estimated risk of treatment). However, IRAs for features rated with low relevance were also generally low, which underlined the existing controversy about the natural history of UIAs. Conclusions— Our results highlight that neurovascular specialists currently consider many features as important when evaluating UIAs but also highlight that the appreciation of natural history of UIAs remains uncertain, even within a group of highly informed individuals.